Estimating Copy Numbers in Cancer Using Hidden Markov Models
Author Information
Author(s): Philippe Lamy, Claus L. Andersen, Lars Dyrskjot, Niels Torring, Carsten Wiuf
Primary Institution: Bioinformatics Research Center, University of Aarhus
Hypothesis
Can a Hidden Markov Model (HMM) effectively estimate allelic copy-number changes in tumor cells using Affymetrix SNP arrays?
Conclusion
The developed HMM method accurately estimates allelic copy-numbers and the mixture proportion of normal and cancer cells in tumor samples.
Supporting Evidence
- The method recovered underlying copy-number changes in simulated data sets with high accuracy (above 97.71%).
- Including the mixture proportion in the HMM increased the accuracy of the method.
- The method was tested on real cancer samples, demonstrating its applicability in clinical settings.
Takeaway
Researchers created a computer model to help understand how many copies of genes are in cancer cells, which can help doctors treat cancer better.
Methodology
The study used a Hidden Markov Model to analyze SNP array data from matched germline-tumor samples to estimate allelic copy-number changes and the proportion of normal cells in tumors.
Limitations
The method's accuracy may be affected by the presence of a mixture of normal and cancer cells, and it may not fully account for tumor heterogeneity.
Participant Demographics
The study involved 38 patients diagnosed with prostate cancer and 29 patients diagnosed with bladder cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website